Barcelona Skin Genomic

Start partnering with us!

Technologies listed below are currently available for transfer. To learn more about our technologie click on the desired technology and click on the orange Contact tech owner button located in the right side of each technology form.

Barcelona Skin Genomic

  • Ignacio Umbert MD.Ph.D

    Ignacio Umbert MD.Ph.D

    For my training in internal medicine (psycho-neuro-immuno-endocrinology), Dermatopathology, dermatology clinic, clinical immunology, I made personalized medicine in the last 20 years. The treatments have been compounding requirements, linking aspects of inflammation and find the source of their causes. My results have been spectacular, obtaining an experience that has allowed me to innovate, and to be able to coach my pacients. To deepen the management of inflammation has led me to genetics, and skin biopsies, and correlate with the expression of genes, and to link with the clinical aspects, it makes the skin is the best scenario to advance personalization of medicine, and have the best results, which has led to the generation of patents.

    View Ignacio's full profile
  • Jordi Valls Margarit

    Jordi Valls Margarit

    Jordi Valls is the project manager at the unit of Biology. Graduated in Biology from the University of Barcelona in 2011, continued his training with the completion of the Master in Biomedicine also taught in the University of Barcelona. Since 2012 has been working on Barcelona Skin Genomic, structuring and performing protocol gene analysis.

    View Jordi's full profile
  • Irena Bonin

    Irena Bonin

    Irena Bonin is the Business Development Manager. Graduated in Pharmacy from the Università degli Studi di Trieste (Italy) specializing in science and drug development. Irena is PhD in biochemistry from the Technical University of Munich (Germany and conducted the doctoral thesis in the laboratory of the Nobel Prize winner, Dr. Robert Huber.

    View Irena's full profile
  • Montse Ribó

    Montse Ribó

    Montserrat Ribó, PhD in Pharmacy and specialist in Pharmaceutical Drug Compounding. She will design personalized and semi standard treatments.

    View Montse's full profile
  • Josep Morral

    Josep Morral

    Jose Ma Morral, pharmaceutical project manager is responsible for the overall area of production, management and coordination of pharmacies nationwide and internationally.

    View Josep's full profile
  • Leonardo Márquez-Kisinousky

    Leonardo Márquez-Kisinousky

    Graduated in Biology from the Autonomous University of Barcelona, and Master in Management and Planning of R&D, Leonardo has more than 10 years of experience as a member of the Higher Council for Sciencitic Research (Consejo Superior de Investigaciones Científicas - CSIC. Has several publications in prestigious

    View Leonardo's full profile
  • Marisa Torrecilla

    Marisa Torrecilla

    Lawyer and MBA - Management and Administration

    View Marisa's full profile
  • QGenomics


    QGenomics is a biotech company, operating in the diagnostic market and based in Barcelona (Catalonia - Spain). We are creating a sustainable and responsible business aiming at bridging genomics research and clinical application for helping our fellow citizens.

  • Leitat


    LEITAT is a Technological Center, member of TECNIO and recognized by the Ministry of Science and Innovation, that aims to collaborate with companies and institutions by adding technological value both to products and processes, and focuses its activity on research, development and industrial innovation (R +D+2i).

BSG - Barcelona Skin Genomic

Telephone +34 932 804 755

Email Address


Address c/Baldiri Reixac, 4-12 and 15, Torre I - 04B07

City Barcelona

Country Spain

About Us

Barcelona Skin Genomic is a company dedicated to personalize treatments for patients who suffer from various skin deases such as: psoriasis, atopic dermatitis and acne. It also performs customized treatments for skin rejuvenation, alopecia, etc.

At present, BSG carries out skin biopsies. The epidermis and dermis are separated using Lase Capture Microdissection (LCM) for subsequent genomic study. Expression microarrays are used to observe differences between different types of samples, whether control skin or damaged skin. Subsequently, BSG manufactures a compound cream formulation based on the results obtained. Once the treatment is completed, a second biopsy is carried out to access the effect the formulation has had on the patient’s skin.

Contact person

Ignacio Umbert MD.Ph.D

Dermatologist / Dermatopathologist

Share this site